Seeking Value: GSK's Drug-Safety AI Strategy Connects Data With Outcomes
GSK and Cognizant aim to cut delays in drug-safety reviews, improve traceability and leave medical decisions to specialists.
Read moreThe top stories in the fields you follow, at 08:00 your time.